TEPROTUMUMAB

Insulin

Brand names: TEPEZZA

Intravenous

Mechanism of Action

12.1 Mechanism of Action Teprotumumab-trbw's mechanism of action in patients with Thyroid Eye Disease has not been fully characterized. Teprotumumab-trbw binds to IGF-1R and blocks its activation and signaling.

Indications

See full prescribing information

Contraindications

• 4 CONTRAINDICATIONS None. None ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS Infusion Reactions : If an infusion reaction occurs, interrupt or slow the rate of infusion and use appropriate medical management ( 5
Assess patients' hearing before, during, and after treatment with TEPEZZA and consider the benefit-risk of treatment with patients ( 5
Assess patients' hearing before, during, and after treatment with TEPEZZA and consider the benefit-risk of treatment with patients

Known Side Effects

9 documented side effects by frequency

Fatigue

>10%

Ringing in Ears

1-10%

Headache

1-10%

Diarrhea

1-10%

Nausea

1-10%

Hair Loss

1-10%

Anxiety

0.1-1%

Drug Not Working

0.1-1%

Weight Loss

0.1-1%

Community Discussions

No community discussions found for TEPROTUMUMAB yet.

Compare With

9 available comparisons

Formulations

Dosage Forms

Tablet

Route

Intravenous